List of works - Shutoku Matsuyama

Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2

scientific article published on 24 June 2020

Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion

scientific article published in October 2019

Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry

scientific article published on 12 October 2016

Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor

scientific article

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

scientific article

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

scientific article published on 12 March 2020

Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.

scientific article published on 22 August 2016

Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells

scholarly article by Shutoku Matsuyama published in October 2018

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

scientific article published on 11 September 2013

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

scientific article

Protease-mediated entry via the endosome of human coronavirus 229E.

scientific article published on 29 October 2008

Receptor-induced conformational changes of murine coronavirus spike protein

scientific article

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

scientific article

Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein

scientific article

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry

scientific article

Soluble receptor potentiates receptor-independent infection by murine coronavirus

scientific article

The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection

scholarly article

The anti-influenza virus drug favipiravir has little effect on replication of SARS-CoV-2 in cultured cells

scholarly article

The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells

scientific article published on 14 October 2020

Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis

scientific article

Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry

scientific article published on 4 December 2017

List of works by Shutoku Matsuyama

Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2

Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion

Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry

Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.

Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

Protease-mediated entry via the endosome of human coronavirus 229E.

Receptor-induced conformational changes of murine coronavirus spike protein

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry

Soluble receptor potentiates receptor-independent infection by murine coronavirus

The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection

The anti-influenza virus drug favipiravir has little effect on replication of SARS-CoV-2 in cultured cells

The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells

Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis

Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry